[Ip-health] US puts India on Priority List - Government of India Press statement - Special 301 is inconsistent with the established norms of the WTO

leena menghaney leenamenghaney at gmail.com
Fri Apr 29 01:12:53 PDT 2016


Press Information Bureau
Government of India
Ministry of Commerce & Industry
25-April-2016 18:06 IST
IPR Issues

India continues to be placed on the Priority Watch List under the US
Special 301 on account of USA’s assessment of Indian IPR protection being
inadequate. The Special 301 Report issued by the United States under their
Trade Act of 1974 is a unilateral measure to create pressure on countries
to enhance IPR protection beyond the TRIPS agreement. Under the WTO regime,
any dispute between two countries needs to be referred to the Dispute
Settlement Body of the WTO and unilateral actions are not tenable under
this regime. Special 301 which is an extra territorial application of the
domestic law of a country is inconsistent with the established norms of the
WTO.

The government is committed to fully utilizing all the flexibilities
provided under the TRIPS agreement to protect domestic pharmaceutical
sector from pressure exerted by the foreign countries. In this regard, it
is also to be mentioned that FDI is permitted in the brownfield Pharma
sector through government approval route only.

This information was given by the Minister of State (Independent Charge) in
the Ministry of Commerce & Industry Smt. Nirmala Sitharaman in a written
reply in Lok Sabha today.
-- 
Leena Menghaney
Mobile: 9811365412



More information about the Ip-health mailing list